Literature DB >> 1701812

Immunologic effects of interferon.

J Knop1.   

Abstract

Interferons can be defined as a family of induced proteins sharing the capacity to exert pleiotropic effects on cell functions and to render cells resistant to virus infection. They are activating genes coding for a number of enzymes, most of which have not yet been characterized, and also by enhancing the synthesis of cell surface components. This enables interferons to modulate the immune response at different levels. This article will focus on the effects of interferon on antigen presentation, regulation of the immune response, activation of macrophage functions, and on its role in the pathogenesis of some diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701812     DOI: 10.1111/1523-1747.ep12874780

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.

Authors:  David M Asmuth; Robert L Murphy; Susan L Rosenkranz; Juan J L Lertora; Shyam Kottilil; Yoninah Cramer; Ellen S Chan; Robert T Schooley; Charles R Rinaldo; Nathan Thielman; Xiao-Dong Li; Sharon M Wahl; Jessica Shore; Jennifer Janik; Richard A Lempicki; Yaa Simpson; Richard B Pollard
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

2.  Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.

Authors:  S A Buechner; M Wernli; T Harr; S Hahn; P Itin; P Erb
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 3.  Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.

Authors:  M Hernberg
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

4.  Interferon-gamma (IFN-gamma) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes.

Authors:  W Coers; J T Vos; P H Van der Meide; M L Van der Horst; S Huitema; J J Weening
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

5.  Podocyte expression of MHC class I and II and intercellular adhesion molecule-1 (ICAM-1) in experimental pauci-immune crescentic glomerulonephritis.

Authors:  W Coers; E Brouwer; J T Vos; A Chand; S Huitema; P Heeringa; C G Kallenberg; J J Weening
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

6.  Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.

Authors:  N Verra; R Jansen; G Groenewegen; H Mallo; M J Kersten; A Bex; F A Vyth-Dreese; J Sein; W van de Kasteele; W J Nooijen; M de Waal; S Horenblas; G C de Gast
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

7.  Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.

Authors:  A Håkansson; B Gustafsson; L Krysander; L Håkansson
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.